James Brumley

James Brumley

InvestorPlace Feature Writer

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Retailer Rotation: Sell These Two, Then Buy This One

By James Brumley, InvestorPlace Feature Writer

There's nothing wrong with either Wal-Mart or Costco, it's just a bad time to step into an investment, and a great time to step out of one -- and into another.

Are Gold Miners the Best Way to Tap Gold?

By James Brumley, InvestorPlace Feature Writer

The assumption is that gold miners are the better way to invest in gold, especially when the price of gold is rising. But when you assume ...

Is Arena Pharmaceuticals Any More Attractive Now That the Dust Is Settling?

By James Brumley, InvestorPlace Feature Writer

Now that the Belviq approval-fueled craze has waned, investors can take a clearer look at Arena's numbers. They might be pleasantly surprised.

Should I Buy Apple? 3 Pros, 3 Cons

By James Brumley, InvestorPlace Feature Writer

When mulling an investment in AAPL, there are plenty of fundamental and technical threads to unravel. But you also have to factor in Apple-mania. See the yay-or-nay verdict.

Watch Out for the Dead-Cat Bounce

By James Brumley, InvestorPlace Feature Writer

Be cautious about deeply-oversold stocks that seem poised for a turnaround -- dead-cat bounces are tricky, especially in today's uncertain market.

4 Mega-Cap Stocks to Buy Now

By James Brumley, InvestorPlace Feature Writer

Just because a company reaches a behemoth size doesn't mean it still doesn't have some untapped upside potential. These four mega-caps apply.

Pharma’s Q2 Earnings Lesson: The Big Picture Looks Good

By James Brumley, InvestorPlace Feature Writer

The promising signs coming out of pharma this quarter doesn't mean you can just pick a stock out of a hat -- but it does mean a few are worth picking.

Cirrus Logic: Too Much Is Too Much

By James Brumley, InvestorPlace Feature Writer

Cirrus has more than doubled this year as optimism over the new iPhone has rolled into a boil. But CRUS shares have painted themselves into a proverbial corner.

Is Sprint Too High to Chase? It Depends

By James Brumley, InvestorPlace Feature Writer

Sprint might be nearing the end of a breakneck rally -- and for interested long-term investors, that actually should end up being a good thing.

5 Real American Dividend Heroes

By James Brumley, InvestorPlace Feature Writer

While the market is doing nothing until further notice, investors should park their cash in these five solid American dividend stocks.

Load More